Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11518772
Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
granted -
US 11512309
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11504390
Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors
granted -
US 11504364
Inhibitors of fibroblast activation protein
granted -
US 11505600
Methods of treating skin cancer by administering a PD-1 inhibitor
granted -
US 11497734
Dual inhibitors of TIM-3 and PD-1 pathways
granted -
US 11497740
Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer
granted -
US 11498928
Macrocyclic spiroethers as Mcl-1 inhibitors
granted -
US 11497781
Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
granted -
US 11498905
Inhibitors of platelet function and methods for use of the same
granted -
US 11492351
MTA-cooperative PRMT5 inhibitors
granted -
US 11492349
IRAK inhibitors and method for making and using
granted -
US 11485760
Inhibitors of CRISPR-Cas9
granted -
US 11485739
Compounds useful as inhibitors of ATR kinase
granted -
US 11485788
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
granted -
US 11485738
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted -
US 11479770
Use of p38 inhibitors to reduce expression of DUX4
granted -
US 11479551
MTA-cooperative PRMT5 inhibitors
granted -
US 11479543
Heterocyclic RIP1 kinase inhibitors
granted -
US 11472782
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 11471442
Administration of gut-selective JAK3 inhibitor
granted -
US 11471528
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 11471448
Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia
granted -
US 11464856
Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
granted